Agios Reports Third Quarter 2017 Financial Results

Go back to Agios Reports Third Quarter 2017 Financial Results

Agios Pharma (AGIO) Tops Q3 EPS by 20c

November 1, 2017 7:14 AM EDT

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.59), $0.20 better than the analyst estimate of ($1.79). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $9.77 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

... More